Cite
HARVARD Citation
Chen, S. et al. (2018). Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes. Journal of acquired immune deficiency syndromes. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, S. et al. (2018). Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes. Journal of acquired immune deficiency syndromes. p. . [Online].